Metastatic Bladder Cancer

13 clinical trials · Condition

Record	Firm	Date
Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab (NCT04887831)	G1 Therapeutics, Inc.	2021-06-04
A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing (NCT06129084)	Bernie Eigl	2021-01-11
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma (NCT04200963)	Ikena Oncology	2019-12-18
A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer (NCT03498196)	Baylor College of Medicine	2018-12-14
Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies (NCT02030067)	Processa Pharmaceuticals	2013-12-01
The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel (NCT01814150)	Gottfried Maya	2013-04-01
Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients (NCT02028442)	Akamis Bio	2012-09-20
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer (NCT01454089)	Achieve Life Sciences	2011-10-01

Every clearance here is in the API, with alerts when new ones post.